In the pain and palliative care – medical care of seriously ill patients cannabinoids occupy an increasingly important place. However, two years after the introduction of the Cannabis law uncertainty, there is still often in the practical application of the different Cannabinoid compounds. Orientation now provides guideline for the new DGS-practice-to “Cannabis in pain therapy”.
In the pain and palliative care – medical care of seriously ill patients cannabinoids occupy an increasingly important place. However, two years after the introduction of the Cannabis law uncertainty, there is still often in the practical application of the different Cannabinoid compounds.
Previously, there was the therapeutic use of cannabinoids are no comprehensive recommendations of a professional society in the German language. This has now taken the German society for pain medicine, with its newly published guideline. The DGS-practice-guidelines take into account not only the external evidence, but also the internal evidence by the experience of the user, as well as the experiences, values and attitudes of the patients. Just for the medical use of cannabinoids you can get for the sole account of the currently available RCT data are often to other assessments as they are reported in the routine Care by the user. The practice-guideline, you can find here.